%0 Journal Article %1 harrison_prospects_2006 %A Harrison, Lee H %D 2006 %J Clinical Microbiology Reviews %K Adolescent, Adult, Aged, Child, Conjugate Design, Drug Humans, Infections, Meningococcal Middle Neisseria Preschool, Serotyping, Vaccination, Vaccines, meningitidis, %N 1 %P 142--164 %R 10.1128/CMR.19.1.142-164.2006 %T Prospects for vaccine prevention of meningococcal infection %U http://www.ncbi.nlm.nih.gov/pubmed/16418528 %V 19 %X Neisseria meningitidis is the leading cause of bacterial meningitis in the United States and worldwide. A serogroup A/C/W-135/Y polysaccharide meningococcal vaccine has been licensed in the United States since 1981 but has not been used universally outside of the military. On 14 January 2005, a polysaccharide conjugate vaccine that covers meningococcal serogroups A, C, W-135, and Y was licensed in the United States for 11- to 55-year-olds and is now recommended for the routine immunization of adolescents and other high-risk groups. This review covers the changing epidemiology of meningococcal disease in the United States, issues related to vaccine prevention, and recommendations on the use of the new vaccine.

@article{harrison_prospects_2006, abstract = {Neisseria meningitidis is the leading cause of bacterial meningitis in the United States and worldwide. A serogroup {A/C/W-135/Y} polysaccharide meningococcal vaccine has been licensed in the United States since 1981 but has not been used universally outside of the military. On 14 January 2005, a polysaccharide conjugate vaccine that covers meningococcal serogroups A, C, W-135, and Y was licensed in the United States for 11- to 55-year-olds and is now recommended for the routine immunization of adolescents and other high-risk groups. This review covers the changing epidemiology of meningococcal disease in the United States, issues related to vaccine prevention, and recommendations on the use of the new vaccine.}, added-at = {2011-03-11T10:05:34.000+0100}, author = {Harrison, Lee H}, biburl = {https://www.bibsonomy.org/bibtex/21e2176864df5142ab9c10b8bc0c119b5/jelias}, doi = {10.1128/CMR.19.1.142-164.2006}, interhash = {a36ae89551cf210eb7b59c193ef8c662}, intrahash = {1e2176864df5142ab9c10b8bc0c119b5}, issn = {0893-8512}, journal = {Clinical Microbiology Reviews}, keywords = {Adolescent, Adult, Aged, Child, Conjugate Design, Drug Humans, Infections, Meningococcal Middle Neisseria Preschool, Serotyping, Vaccination, Vaccines, meningitidis,}, month = jan, note = {{PMID:} 16418528}, number = 1, pages = {142--164}, timestamp = {2011-03-11T10:05:53.000+0100}, title = {Prospects for vaccine prevention of meningococcal infection}, url = {http://www.ncbi.nlm.nih.gov/pubmed/16418528}, volume = 19, year = 2006 }